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BACKGROUND: The prevalence of diabetes mellitus is growing every year, including in Indonesia. Medicinal herbs were used empirically 
for lowering blood glucose. One of potential herb to have 
hypoglycemic activity is Stevia. Stevia rebaudiana Bertoni 
leaves contain stevoside, a natural, low-calorie sweetener 
that is 300 times sweeter than saccharose. In this study, we 
aimed to explore the hypoglycemic activity of S. rebaudiana 
Bertoni leaves extract in a rat model of type 2 diabetes 
mellitus (T2DM). 
METHODS: Male Wistar rats were feed high-fat, high-
carbohydrate feed and sugar solution for 74 days to induce a 
diabetic rat model. The animals were then divided into five 
groups consisting of a negative control group treated with 
2% Pulvis Gom Arabicum; a positive control group treated 
with Metformin 45 mg/kg body weight (BW); and three 
test groups treated with aqueous extract of S. rebaudiana 
Bertoni leaves at doses of 3.125, 6.25 and 12.5 mg/kg BW 
for 36 days. Blood glucose was measured on days 14, 28 
and 36.  
RESULTS: The results showed that blood glucose levels 
over 36 days were significantly (p=0.043) lower in the group 
treated with S. rebaudiana Bertoni leaves extract. Further 
Newman-Keuls analysis suggested that the hypoglycemic 
activity of S. rebaudiana Bertoni leaves extract was dose-
dependent. 
CONCLUSION: Our results indicate that S. rebaudiana 
Bertoni leaves extract has a potential role as a hypoglycemic 
agent in the treatment of T2DM.
KEywORDS: Stevia rebaudiana Bertoni, nutraceuticals, 
hypoglycemic, diabetic rats
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Abstract
Introduction
Type 2  Diabetes  Mellitus  (T2DM)  is  metabolic  disorder 
that punctuated by insulin resistance. Some factors 
may trigger T2DM such as consumption of high calorie 
intake, obesity, sedentary lifestyle, as well as genetic.(1,2) 
More than 80% of all patients with diabetes are T2DM. 
Epidemiological research in developed countries showed 
that due to high older population structure and high rates 
of obesity, the incidence and prevalence of T2DM are 
increasing. According to World Health Organization 
estimation, Indonesia has the fourth largest diabetic 
population in the world after India, China, and the United 
States.(3)
 Indonesia is the third most bio-diverse country in Asia, 
after India and China, possessing rich resources of medicinal 
herbs with the potential to act as hypoglycemic agents. 
The extract of Stevia rebaudiana Bertoni (S. rebaudiana; 
Asteraceae), a herbaceous plant, has been used for many 
years in the treatment of diabetes among indigenous people 
of Paraguay and Brazil.(4,5) 
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 S. rebaudiana Bertoni leaves contain stevioside, a 
natural, low-calorie sweetener that is 300 times sweeter 
than saccharose. A number of recent studies revealed that 
consumption of S. rebaudiana Bertoni can lower the plasma 
glucose level.(5-7) Aquatic extract of S. rebaudiana Bertoni 
can stimulate insulin secretion, sensitivity by acting directly 
on pancreatic beta cells, and showed antioxidant properties.
(4,8,9) Furthermore, stevioside and steviol that extracted 
from S. rebaudiana Bertoni showed to increase expresion of 
glucose transporter type 4 (GLUT4) gene and protein, and 
also glucose uptake in cells.(10)
 Previous studies started the extraction of stevioside 
from S. rebaudiana Bertoni leaves were using water- or 
alcohol-based extraction and followed by purification, 
filtration, and identification by high performance liquid 
chromatography (HPLC), nuclear magnetic resonance 
(NMR), and mass spectrometry (MS).(11) Stevioside and 
other 20 compounds that isolated from S. rebaudiana 
Bertoni leaves were extracted from hot water.(12)
 A beverage prepared from S. rebaudiana Bertoni 
leaves caused a 35% reduction in blood glucose in humans. 
This indicates that S. rebaudiana Bertoni leaves extract 
possesses  blood-glucose-lowering  properties  and  may  be 
a potential treatment for diabetes mellitus.(13-15) The aim 
of this study was to determine the hypoglycemic activity of 
S. rebaudiana Bertoni leaves aqueous extract in a rat model 
of T2DM.
Methods
Plant Material
S. rebaudiana Bertoni leaves were collected from Manoko 
Lembang, Jawa Barat, Indonesia. Plants were identified in 
the Plant Taxonomy Laboratory, Department of Biology, 
Faculty of Natural Sciences, Universitas Padjadjaran, with 
the identification number 560/HB/II/2016. The result of 
the identification process indicated that the plant samples 
used in this study were S. rebaudiana Bertoni species 
from the Asteraceae family. S. rebaudiana Bertoni leaves 
were cleaned and dried at room temperature then chopped 
into small slices. The small leaf slices were extracted 
with distilled water and freeze dried. The freeze-dried S. 
rebaudiana Bertoni leaves was stored at 4°C until used in 
assays.
Diabetic Rat Model Preparation
Male Wistar rats 2-3 months old and weighing approximately 
150-250 g were used in the model. All rats were acclimatized 
to the new environment for 1 week prior to treatment, 
housed under standard laboratory conditions with a 12:12 h 
light/dark cycle, fed in pellet feed and water ad libitum. Rats 
were divided into two groups; normal group and diabetic 
rats groups. Normal rat group were fed with commercially 
available rat standard pellet diet and diabetic rat groups 
were fed with high-fat, high-carbohydrate pellet diet that 
feed 20 g/rat/day and 10% sugar solution for 74 days to 
induce T2DM (without aqueous extract of S. rebaudiana 
Bertoni leaves). A fasting blood glucose level of ≥110 mg/
dL was the criterion for T2DM in high fat and high fructose 
diet fed rat.(16,17) Blood glucose levels were measured by 
using glucometer strips.
Hypoglycemic  Activity  of  S. rebaudiana Bertoni leaves 
Extract  in Diabetic Rats
Diabetic rats were divided into five groups (each group 
consisting of five rats) as follows: the negative control 
group was treated with 2% Pulvis Gom Arabicum (PGA), 
the positive control group was treated with Metformin 
45 mg/kg body weight (BW) in 2% PGA. The three test 
groups were treated with freeze-dried aqueous extract of S. 
rebaudiana Bertoni leaves in 2% PGA at doses of 3.125 mg/
kg BW (Group 1), 6.25 mg/kg BW (Group 2), and 12.5 mg/
kg BW (Group 3) once a day for 36 days. During treatment 
with the aqueous extract of S. rebaudiana Bertoni leaves, 
all the animal groups were fed high-fat, high-carbohydrate 
feed and 10% sugar solution. Blood samples were taken 
by cutting the tip of the rat’s tail, and blood glucose levels 
were measured on days 0, 14, 28 and 36 after treatment with 
aqueous extract of S. rebaudiana Bertoni leaves. Before 
blood sampling, the rats were fasted for 8-12 hours, to 
eliminate interference of consumed food with blood glucose 
levels. BW was also measured on day 0, 14, 28 and 42 after 
treatment.
 All procedures involving animal subjects were 
performed  in  accordance  with  the  institutional  and/
or national research ethical standards and approved 
by Universitas Padjadjaran Medical Research Ethics 
Committee number 1150/UN6C1.3.2/KEPK/PN/2016.
Statistical Analysis
The data were presented in mean±SD. The statistical 
significance were analyzed using paired Student’s t-tests.
T2DM Rat Model Induction
The rat model of T2DM was induced by high-fat, high-
carbohydrate feed and 10% sugar solution. Fasting blood 
Results
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Figure 1. The average of fasting blood glucose 
level in induction of T2DM. All the rat groups were 
fed by high fat-high carbohydrate feed and 10% 
sugar solution until blood glucose level ≥110 mg/dL 
for 0, 42, 56 and 74 days.
Group p- value
 C (-) 0.0001
 C (+) 0.0000
 Group 1 0.0002
 Group 2 0.0001
 Group 3 0.0240
Table 1. The p-value of student’s t-test on fasting blood glucose 
levels of high fat, high and 10% sucrose-induced rat in day 74 
compared to day 0.
glucose was increased slightly at days 42 and 56 and met 
the criteria for T2DM (≥110 mg/dL) at day 74 (Figure 1). At 
day 74, the T2DM rat model had an average fasting blood 
glucose level was 129.8±5.9 mg/dL.
 The results showed that high-fat, high-carbohydrate 
feed and 10% sugar solution produced a T2DM rat model 
similar to a sedentary lifestyle as a factor for T2DM in 
humans. Fasting blood glucose levels were increased 
significantly in all groups at day 74 compared with day 0 
(p≤0.05) (Table 1). The BWs of T2DM model rats were 
measured every 2 weeks following induction of T2DM. The 
BWs of all groups were increased by induction with high-
fat, high-carbohydrate feeding and 10% sugar solution.
Hypoglycemic Activity of S. rebaudiana Bertoni leaves
Evaluation of the hypoglycemic activity of freeze-dried 
S. rebaudiana Bertoni leaves extract was carried out to 
determine  the potential  of  the  extract  to  lower  blood 
glucose levels effectively. The mean fasting blood glucose 
levels of rats during the treatment were calculated (Figure 
2, Table 2). Day 0 refers to day 0 of S. rebaudiana Bertoni 
leaves extract-treatment, which is day 74 after induction. 
Treatment with S. rebaudiana Bertoni leaves extract for 
5 weeks decreased fasting blood glucose levels in a time- 
and dose-dependent manner. The higher the dose of S. 
rebaudiana Bertoni leaves extract, the higher the observed 
blood-glucose-lowering activity. 
 In the positive control group (Metformin) and the test 
group (S. rebaudiana Bertoni leaves aqueous extract), at 
several dose levels, the mean fasting blood glucose level was 
decreased by 43.33% and 38.6%, respectively. Statistical 
analysis using analysis of variance showed a significant 
difference with each treatment in the parameter measured 
at α=0.05. This means that each treatment had a significant 
blood-glucose-lowering effect at the 95% confidence level 
(Table 3). Treatment with S. rebaudiana Bertoni leaves 
extract significantly decreased fasting blood glucose levels 
at the 36th day in the Metformin group (p=0.042) and Group 
3 (p=0.043) rats according to analysis by Student’s t-test 
(Figure 2).
 BW increases in the T2DM rat model after induction 
and treatment with S. rebaudiana Bertoni leaves extract are 
shown in Figure 3. From the graph shown, it can be observed 
that after a total 116 days of high-calorie sugar induction 
and treatment with S. rebaudiana Bertoni leaves extract, 
all animals in three test groups and two control groups had 
gained BW.
Discussion
In all groups of rats, T2DM was induced by high-fat, high-
carbohydrate feeding and 10% sugar solution, mimicking 
the sedentary lifestyle that stimulates T2DM development 
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Figure 2. The average of blood glucose level 
fasting rats graph during 36 days of treatment. 
*p<0.05 vs. negative control at day 36.
Day 0: The blood glucose levels of rats before treated; C(-): 
Negative Control (PGA 2%); C(+): Positive Control (PGA 2% + 
Metformin 45 mg/g BW); Group 1: PGA 2% + stevia water extract 
with a dose of 3.125 mg/kg BW; Group 2: PGA 2% + stevia water 
extract with a dose of 6.25 mg/kg BW; Group 3: PGA 2% + stevia 
water extract with a dose of 12.5 mg/kg BW.
Day 0 Day 14 Day 28 Day 36
C(-) 126.2±10.92 117.4±22.45 109.2±21.80 111.4±32.42
C(+) 132.6±3.29 112.2±7.60 97.4±9.18 75±9.22
Group 1 131.8±4.55 109.2±16.57 94.8±14.79 84±15.25
Group 2 127.8±8.35 106±14.14 96±16.72 79.4±14.88
Group 3 130.6±2.51 108±2.92 92±19.99 76.2±14.14
Group
The Average of Fasting Glucose Levels of Rats
 (mg/dL)
Table 2. The average of fasting glucose levels of rats during 36 
days of treatment.
in humans. In the present study, we did not use alloxan or 
streptozotocin, because they destroy the pancreatic β cells 
and mimic type 1 diabetes mellitus.(18-20) Although high 
fat and high carbohydrate feed induced T2DM showed some 
limitation, but these induction established suitable condition 
for obesity and T2DM in etiology, pathology and treatment.
(21) Our previous study also using high fat diet-fed mouse 
in safrol-free nutmeg seed extract to establish T2DM mouse 
model.(22) One of limitation of present study that insulin 
level was not measured during the treatment and to confirm 
T2DM progression in diabetic rats.
 High-fat and high-carbohydrate diets will increase the 
fat level in the blood, stimulate fat metabolism, and produce 
reactive oxygen species (ROS) in the blood and adipose 
cells. Increasing the production of ROS in adipose cells 
will disturb the balance of redox reactions. Furthermore, 
it will decrease the amount of antioxidant enzymes in the 
circulation, producing oxidative stress.(23,24) Hence, 
glucose uptake in muscle cells and fat cells will be inhibited 
and insulin secretion by pancreatic β cells will be decreased. 
Oxidative stress also directly affects vascular membranes 
and plays a pivotal role in the pathophysiology of T2DM 
and atherosclerosis.(25)
 S. rebaudiana Bertoni as a herbal plant shows 
promising activity as a T2DM therapy or supplement. In the 
present study, we observed that freeze-dried S. rebaudiana 
Bertoni leaves extract decreased the blood glucose level 
in a T2DM rat model at a small dose (12.5 mg/kg BW). 
With high-fat, high-carbohydrate and 10% sugar solution 
feeding, the BWs of S. rebaudiana Bertoni leaves extract-
treated rat groups was increased, but the blood glucose 
levels were decreased significantly. This result indicates that 
S. rebaudiana Bertoni may control blood glucose levels in a 
T2DM rat model.
 In previous studies, 400 mg/kg BW of aquatic extract of 
S. rebaudiana Bertoni leaves was observed to lower fasting 
blood glucose, triglycerides, and hepatic parameters after 28 
days of treatment.(8) A methanol extract of S. rebaudiana 
Bertoni root treatment in diabetic rats was observed to 
lower blood glucose levels, increase the hepatic glycogen 
content, and maintain BW and lipid-profile parameters in 
the near-normal range.(9) A study of S. rebaudiana Bertoni 
as a sweet herb (1 g S. rebaudiana Bertoni leaves powder) 
in T2DM subjects significantly lowered fasting and post-
prandial blood glucose levels, triglycerides, and very low-
density lipoprotein cholesterol (VLDL-C) levels.(15)
 The sweet taste of S. rebaudiana Bertoni  comes 
from stevioside which is a glycosidic diterpenes, that has 
300 times sweeter than sucrose with zero calorie.(26,27) 
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Table 3. The p-value of Student’s t- test on fasting blood 
glucose levels of diabetic rat after treatment with S. rebaudiana 
Bertoni extract in day 36 compare to negative control group.
Day 14 Day 28 Day 36
 C (+) 0.6368 0.297 0.0422*
 Group 1 0.5295 0.2564 0.1256
 Group 2 0.3648 0.314 0.0798
 Group 3 0.3802 0.2297 0.0431*
p- value
Groups
*significant p<0.05.
BW
 (g
)
Time (Day)
250
150
350
300
200
 0              74            88           102          116 Figure 3. Increasing Bw in T2DM-rats model after induction 
and treatment of S. rebaudiana Bertoni extract.
Mechanistically, S. rebaudiana Bertoni  lowers blood 
glucose levels by increasing insulin secretion and decreasing 
glucagon secretion in α-pancreatic cells. Stevioside, which 
is the major compound of S. rebaudiana Bertoni, has the 
effect of stimulating insulin secretion and increasing insulin 
sensitivity by acting directly on pancreatic beta cells.
(28,29) Another study showed that S. rebaudiana Bertoni 
extract increased the expression of peroxisome proliferator-
activated receptor-γ (PPARγ) and insulin mRNA.(8) PPARγ 
plays an important role in maintaining glucose metabolism 
by stimulating glucokinase and GLUT2 in the pancreas 
and liver.(30) By increasing the expression of PPARγ and 
GLUT4, stevioside will enhance the glucose uptake into 
the cells, thereby glucose in blood were metabolized and 
resulting in lowering blood glucose level.(30)
 The finding that the aqueous extract of S. rebaudiana 
Bertoni could increase the BW of a rat animal model in this 
study could be very valuable to the supplementary use of 
S. rebaudiana Bertoni, since most diabetic patients struggle 
with significant BW loss due to strict limitation of the blood 
glucose level. In contrast, another study that used birds as 
an animal model has proven that S. rebaudiana Bertoni 
leaves used as a poultry food supplement could contribute 
to increasing the abdominal fat content. The mechanism by 
which S. rebaudiana Bertoni acts to increase broiler BW is 
by it component stevioside increasing glucose intake from 
the vascular blood, which is later converted to fat and stored 
in the abdomen of test animals.(31)
 The  insulin  resistance  caused  high  blood  glucose 
level in diabetic subjects can decrease BW through 
gluconeogenesis in liver which are producing endogenous 
glucose from fat. This condition showed a metabolic 
disturbance.(32) S. rebaudiana Bertoni consumption 
increasing insulin secretion, increase insulin sensitivity, 
and decreasing glucagon secretion in α-pancreatic cells. 
Therefore, gluconeogenesis is decreased, lipolysis 
is decreased or stops. Hence, S. rebaudiana Bertoni 
consumption will improve the metabolism and homeostatic 
BW can be arisen. However, further studies on how S. 
rebaudiana Bertoni could increase BW in a rat model 
should be performed to clarify these results.
Conclusion
Aqueous extract of S. rebaudiana Bertoni leaves at doses 
of 3.125 mg/kg BW, 6.25 mg/kg BW and 12.5 mg/kg BW 
can lower blood glucose levels significantly. The percentage 
decrease in blood  glucose levels was correlated with the 
given dose, and the greatest decrease in the blood  was 
obtained from a dose of 12.5 mg/kg BW of 38.6% in a 
T2DM rat model. Based on the analysis, stevia extract has 
potential dose-dependent hypoglycemic activity.
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